Baseline and Early Predictors of Good Patient Candidates for Second-Line after Sorafenib Treatment in Unresectable Hepatocellular Carcinoma

Background: Recent advances in the development of tyrosine kinase inhibitors (TKIs) have enabled patients with unresectable hepatocellular carcinoma (HCC) to receive multiple TKIs in sequence. The aim of this study was to identify predictors of good candidates for second-line treatment after disease...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Takada, Hitomi, Kurosaki, Masayuki, Tsuchiya, Kaoru, Komiyama, Yasuyuki, Itakura, Jun, Takahashi, Yuka, Nakanishi, Hiroyuki, Yasui, Yutaka, Tamaki, Nobuharu, Maeyashiki, Chiaki, Kaneko, Shun, Takaura, Kenta, Higuchi, Mayu, Okada, Mao, Wang, Wan, Osawa, Leona, Sekiguchi, Shuhei, Hayakawa, Yuka, Yamashita, Koji, Enomoto, Nobuyuki, Izumi, Namiki
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6770447/
https://ncbi.nlm.nih.gov/pubmed/31461985
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11091256
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados